Related Experiment Video
Updated: Apr 19, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Inhibitory effects of dobutamine on human gastric adenocarcinoma
Hui-Xia Zheng1, Li-Na Wu1, Hong Xiao1
1Hui-Xia Zheng, Li-Na Wu, Hong Xiao, Qian Du, Jian-Fang Liang, Department of Pathology, The First Hospital, Shanxi Medical University, Taiyuan 030024, Shanxi Province, China.
Aim:
To explore the inhibitory effects of dobutamine on gastric adenocarcinoma cells.
Methods:
Dobutamine was used to treat gastric adenocarcinoma cells (SGC-7901) and cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The effects of dobutamine combined with cisplatin on cell viability were also analyzed. Cell migration was studied using the wound healing assay, and cell proliferation was analyzed using the colony formation assay. A cell invasion assay was carried out using Transwell cell culture chambers. The cell cycle and cell apoptosis were analyzed by flow cytometry. Western blot and immunocytochemistry were performed to determine the expression of Yes-associated protein (YAP) in treated cells.
Results:
Dobutamine significantly inhibited cell growth, migration, cell colony formation, and cell invasion into Matrigel. Dobutamine also arrested the cell cycle at G1/S phase, and increased the rate of apoptosis of gastric adenocarcinoma cells. The expression of YAP was detected mainly in the nucleus in the absence of dobutamine. However, reduced expression of phosphorylated YAP was mainly found in the cytosol following treatment with dobutamine.
Conclusion:
Dobutamine has significant inhibitory effects on gastric adenocarcinoma cells and may be used in neoadjuvant therapy not only for gastric cancer, but also for other tumors.
Insights
Dobutamine effectively inhibits gastric adenocarcinoma cell growth, migration, and invasion. This drug also induces apoptosis and cell cycle arrest, suggesting potential as a neoadjuvant therapy for gastric cancer.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Gastric adenocarcinoma is a significant global health concern.
- Exploring novel therapeutic agents for gastric cancer is crucial.
Purpose of the Study:
- To investigate the inhibitory effects of dobutamine on gastric adenocarcinoma cells.
- To evaluate dobutamine's impact on cell viability, proliferation, migration, invasion, cell cycle, and apoptosis.
Main Methods:
- Utilized gastric adenocarcinoma cells (SGC-7901) treated with dobutamine.
- Assessed cell viability (MTT assay), migration (wound healing), proliferation (colony formation), invasion (Transwell assay).
- Analyzed cell cycle and apoptosis (flow cytometry), and Yes-associated protein (YAP) expression (Western blot, immunocytochemistry).
Main Results:
- Dobutamine significantly inhibited cell growth, migration, colony formation, and invasion.
- Dobutamine induced G1/S phase cell cycle arrest and increased apoptosis.
- Dobutamine treatment altered YAP expression, with reduced phosphorylated YAP in the cytosol.
Conclusions:
- Dobutamine exhibits significant inhibitory effects on gastric adenocarcinoma cells.
- Dobutamine shows promise as a neoadjuvant therapy for gastric cancer and potentially other tumors.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
10:31Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Heart Failure Drugs: Inotropic Agents
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
GPCRs Regulate Adenylyl Cylase Activity
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Gastric Emptying